Medpace Holdings Inc
Uždarymo kaina
SektoriusSveikatos priežiūra
458.38 0.52
Apžvalga
Akcijų kainos pasikeitimas
24 val.
Min
448.44
Max
460.92
Pajamos | -11M 124M |
|---|---|
Pardavimai | -1.8M 707M |
P/E Sektoriaus vid. | 29.031 49.712 |
Pelnas, tenkantis vienai akcijai | 4.28 |
Pelno marža | 17.53 |
Darbuotojai | 6,300 |
EBITDA | -9.5M 154M |
Rekomendacijos | Pirkti |
|---|---|
12 mėnesių prognozė | -1.07% downside |
Kitas uždarbis | 2026-07-22 |
|---|
Rinkos kapitalizacija | -1.9B 13B |
|---|---|
Ankstesnė atidarymo kaina | 457.86 |
Ankstesnė uždarymo kaina | 458.38 |
Naujienos nuotaikos
By Acuity
26%
74%
60 / 342 reitingas Healthcare
Medpace Holdings Inc Grafikas
Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.
Apie bendrovę Medpace Holdings Inc
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.